Literature DB >> 20842551

Current concepts in the management of chronic mesenteric ischemia.

Gustavo S Oderich1.   

Abstract

OPINION STATEMENT: Treatment of chronic mesenteric ischemia has evolved during the past two decades. Endovascular treatment has emerged as an alternative to bypass in elderly and higher-risk patients and is now the primary treatment modality for most patients with suitable lesions, independent of their surgical risk. Open surgical revascularization still has an important role for patients with more extensive disease, including those with long-segment stenosis or occlusions, small vessel diameter, multiple tandem lesions, or severe calcification. This article summarizes current concepts in the epidemiology, natural history, treatment selection, and outcomes of open and endovascular mesenteric reconstruction for chronic mesenteric ischemia.

Entities:  

Year:  2010        PMID: 20842551     DOI: 10.1007/s11936-010-0061-1

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  53 in total

1.  Technical consideration in the management of chronic mesenteric ischemia.

Authors:  Michael A Leke; Douglas B Hood; Vincent L Rowe; Steven G Katz; Roy D Kohl; Fred A Weaver
Journal:  Am Surg       Date:  2002-12       Impact factor: 0.688

2.  Stent placement with the monorail technique for treatment of mesenteric artery stenosis.

Authors:  Philipp J Schaefer; Fritz K W Schaefer; Holger Hinrichsen; Thomas Jahnke; Nikolas Charalambous; Martin Heller; Stefan Mueller-Huelsbeck
Journal:  J Vasc Interv Radiol       Date:  2006-04       Impact factor: 3.464

3.  Elective surgical treatment of symptomatic chronic mesenteric occlusive disease: early results and late outcomes.

Authors:  R B Mateo; P J O'Hara; N R Hertzer; E J Mascha; E G Beven; L P Krajewski
Journal:  J Vasc Surg       Date:  1999-05       Impact factor: 4.268

4.  Endovascular repair of chronic mesenteric occlusive disease: the role of duplex surveillance.

Authors:  Joanna L Fenwick; Isabel A Wright; Tim M Buckenham
Journal:  ANZ J Surg       Date:  2007 Jan-Feb       Impact factor: 1.872

5.  Endovascular treatment of chronic mesenteric ischemia: results in 14 patients.

Authors:  Tamam Chahid; Agaicha T Alfidja; Marie Biard; Anne Ravel; Jean Marc Garcier; L Boyer
Journal:  Cardiovasc Intervent Radiol       Date:  2004-10-06       Impact factor: 2.740

6.  Open versus endovascular revascularization for chronic mesenteric ischemia: risk-stratified outcomes.

Authors:  Gustavo S Oderich; Thomas C Bower; Timothy M Sullivan; Haraldur Bjarnason; Stephen Cha; Peter Gloviczki
Journal:  J Vasc Surg       Date:  2009-06       Impact factor: 4.268

7.  Mesenteric revascularization: management and outcomes in the United States, 1988-2006.

Authors:  Marc L Schermerhorn; Kristina A Giles; Allen D Hamdan; Mark C Wyers; Frank B Pomposelli
Journal:  J Vasc Surg       Date:  2009-04-16       Impact factor: 4.268

8.  Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: a comparative experience.

Authors:  Marvin D Atkins; Christopher J Kwolek; Glenn M LaMuraglia; David C Brewster; Thomas K Chung; Richard P Cambria
Journal:  J Vasc Surg       Date:  2007-04-30       Impact factor: 4.268

9.  Stent implantation in chronic mesenteric ischemia.

Authors:  C Aksu; G Demirpolat; I Oran; G Demirpolat; M Parildar; A Memis
Journal:  Acta Radiol       Date:  2009-07       Impact factor: 1.990

10.  Mid-term outcome of endovascular revascularization for chronic mesenteric ischaemia.

Authors:  N V Dias; S Acosta; T Resch; B Sonesson; A Alhadad; M Malina; K Ivancev
Journal:  Br J Surg       Date:  2010-02       Impact factor: 6.939

View more
  1 in total

1.  A case of pancreatic cancer invading the superior mesenteric artery causing extensive intestinal necrosis that was successfully treated by surgery.

Authors:  Nobuhito Nitta; Yusuke Yamamoto; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Katsuhisa Ohgi; Katsuhiko Uesaka
Journal:  J Surg Case Rep       Date:  2019-04-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.